Monsanto Co. (MON)

2,550.00
64.00 2.45
Prev Close 2,614.00
Open 2,600.00
Day Low/High 2,550.00 / 2,600.00
52 Wk Low/High 2,020.00 / 2,614.00
Volume 13.00
Avg Volume 4.52M
Exchange n.a.
Shares Outstanding 441.28M
EPS 5.20
Div & Yield 2.16 (0.00%)
Stocks Rocket Higher After Week of Rates Worry

Stocks Rocket Higher After Week of Rates Worry

Who's afraid of the big, bad Fed? Not Wall Street. Not anymore.

Tech Leads Wall Street Rally as Rate Hike Fears Fade

Tech Leads Wall Street Rally as Rate Hike Fears Fade

Stocks rocket higher on Tuesday as the fears over rate hikes that have plagued Wall Street for nearly a week begin to fade.

Cramer: It's Catalyst City for Market Rally

Oil, takeovers, tech, new-home sales -- all that and more drive stocks higher.

Monsanto (MON) Stock Up, Rejects Bayer’s $62 Billion Takeover Offer

Monsanto (MON) Stock Up, Rejects Bayer’s $62 Billion Takeover Offer

Monsanto (MON) stock is advancing on Tuesday afternoon as the company said it is open to deal talks with Bayer (BAYRY) but views its current $62 billion offer as 'inadequate.'

Basic Materials Stocks On The Rise With Help From 3 Stocks

Basic Materials Stocks On The Rise With Help From 3 Stocks

TheStreet highlights 3 stocks pushing the basic materials sector higher today.

Monsanto Views Bayer's Current Proposal As Incomplete And Financially Inadequate; Company Open To Discussing Potential Path Forward That Would Create Appropriate Value For Monsanto Shareowners

Monsanto Views Bayer's Current Proposal As Incomplete And Financially Inadequate; Company Open To Discussing Potential Path Forward That Would Create Appropriate Value For Monsanto Shareowners

Monsanto Company (NYSE: MON) today announced that its Board of Directors unanimously views the Bayer AG proposal as incomplete and financially inadequate, but is open to continued and constructive conversations to assess...

Monsanto Has a Bright Future, With or Without Bayer

Monsanto Has a Bright Future, With or Without Bayer

Investors are skeptical about the possible $62 billion combination, but the agricultural biotechnology company offers long-term potential, regardless.

Monsanto (MON) Stock Gains, Said to Reject Bayer Bid and Seek Higher Price

Monsanto (MON) Stock Gains, Said to Reject Bayer Bid and Seek Higher Price

Monsanto (MON) stock is climbing on Monday morning as the company will reportedly reject Bayer’s (BAYRY) $62 billion acquisition bid and seek a higher price.

Wall Street Looking Real Hard at Bayer's Bid for Monsanto

Wall Street Looking Real Hard at Bayer's Bid for Monsanto

Bayer says there's logic behind its $62 billion bid for the agricultural company. Analysts are not so sure.

Wall Street Still Dubious Over Bayer's $62 Billion Bid for Monsanto

Bayer spells out the logic behind its bid for the agricultural giant, citing the creation of an 'innovation powerhouse.'

Stocks Struggle as Wall Street Weighs Odds of June Hike

Stocks Struggle as Wall Street Weighs Odds of June Hike

Wall Street weighed the odds of a June rate hike, and the uncertainty left markets paralyzed for much of Monday's session.

S&P 500 Struggles for Gains as Rate Hike Worries Paralyze Markets

S&P 500 Struggles for Gains as Rate Hike Worries Paralyze Markets

The Federal Reserve remains in focus on Monday with speculation over a June rate hike leading to choppy trading.

Trending Tickers: XNPT, OLED, MON, TPUB

Monsanto rises and Tribune Publishing sinks on separate merger bids.

Cramer Isn't Sold That Bayer's Monsanto Bid Will Pass Reg Tests

Cramer Isn't Sold That Bayer's Monsanto Bid Will Pass Reg Tests

German company Bayer offers a 37% premium to its St. Louis target's undisturbed share price.

Monsanto (MON) Stock Climbing as Bayer Makes $62 Billion Offer, Jim Cramer's View

Monsanto (MON) Stock Climbing as Bayer Makes $62 Billion Offer, Jim Cramer's View

Monsanto (MON) stock is advancing on Monday morning after Bayer (BAYRY) offered to buy the company for $62 billion in cash.

More Squawk From Jim Cramer: Monsanto (MON), Bayer Deal 'Ain't Happening'

More Squawk From Jim Cramer: Monsanto (MON), Bayer Deal 'Ain't Happening'

Monsanto (MON) and Bayer (BAYRY) don't have a sense of the current regulatory environment, Jim Cramer says.

Jim Cramer Doubts Bayer's Bid for Monsanto Will Win Approval

Jim Cramer Doubts Bayer's Bid for Monsanto Will Win Approval

Monsanto formally received a $62 billion takeover bid from Bayer which is valued at $122 a share.

Stocks Struggle for Direction on Possibility of June Rate Hike

Stocks Struggle for Direction on Possibility of June Rate Hike

Stocks struggle for direction on Monday morning as the possibility of a rate hike in June continues to loom large over Wall Street.

Trade-Ideas: Monsanto (MON) Is Today's Unusual Social Activity Stock

Trade-Ideas: Monsanto (MON) Is Today's Unusual Social Activity Stock

Trade-Ideas LLC identified Monsanto (MON) as an unusual social activity candidate

Cramer: Farmers Won't Stand for Bayer Deal With Monsanto

Cramer: Farmers Won't Stand for Bayer Deal With Monsanto

There's no way Bayer's potential takeover of Monsanto can survive heightened government opposition to deals perceived as curbing competition, says TheStreet's Jim Cramer.

U.S. Stocks Open Mixed on Fed Rate Hike Worries; Boeing Scores $11.3 Billion Order

U.S. Stocks Open Mixed on Fed Rate Hike Worries; Boeing Scores $11.3 Billion Order

U.S. stocks opened mixed on Monday as investors feared a sooner-than-excepted Fed rate hike.

The Bayer-Monsanto Deal Is a Necessity, Analyst Says

The Bayer-Monsanto Deal Is a Necessity, Analyst Says

Bayer offered to acquire Monsanto for $62 billion on Monday, a deal one analyst called a 'necessity.'

Stock Futures Mixed on More Talk of June Rate Hike

Stock Futures Mixed on More Talk of June Rate Hike

Stock futures are narrowly mixed on Monday morning as the possibility of a June rate hike looms large over Wall Street.

Rev's Forum: You Should Focus on Short-Term Trading for Now

The bears' arguments aren't enough to kill the positive price action.

May 23 Premarket Briefing: 10 Things You Should Know

May 23 Premarket Briefing: 10 Things You Should Know

U.S. stock futures are rising slightly on Monday while European stocks trade mixed as data points to further evidence of subdued growth in the eurozone.

European Stock Markets Lurch; Fiat Chrysler Falls on Emissions Worries

European Stock Markets Lurch; Fiat Chrysler Falls on Emissions Worries

Bayer declines as it confirms a rights issue is on the agenda if a $62 billion takeover run at Monsanto succeeds.

Coca-Cola, Foot Locker and Monsanto: Doug Kass' Views

Coca-Cola, Foot Locker and Monsanto: Doug Kass' Views

Doug Kass shares his thoughts on how to navigate. He remains anticipatory.

Jim Cramer's 'Mad Money' Recap: These Stocks Still Sweet Despite Sour Market

Jim Cramer's 'Mad Money' Recap: These Stocks Still Sweet Despite Sour Market

There are lots of stocks still working in this market, and Cramer tells you which ones.

Stocks Pare Losses but Remain in Red on Rate Hike Fears

Stocks Pare Losses but Remain in Red on Rate Hike Fears

A higher probability the Federal Reserve could implement another rate hike in June sends shares sharply lower on Thursday.

Monsanto and the Big Agribusiness Merger Trend

Monsanto and the Big Agribusiness Merger Trend

Monsanto started the agribusiness/chemical merger trend with its pursuit of Syngenta. A year later, consolidation is rampant.